Lanthanum Carbonate (Lupin Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Lanthanum Carbonate drug offered from Lupin Pharmaceuticals, Inc.. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lupin Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Lanthanum Carbonate
SUBSTANCE NAME: LANTHANUM CARBONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-08-30
END MARKETING DATE: 0000-00-00


Lanthanum Carbonate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLanthanum Carbonate from Lupin Pharmaceuticals, Inc.
LABELER NAME: Lupin Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2017-08-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68180-819_b17bd970-46f9-468a-9761-5a98db72aa70
PRODUCT NDC: 68180-819
APPLICATION NUMBER: ANDA090978

Other LANTHANUM CARBONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFosrenol
Cardinal HealthFosrenol
Lupin Pharmaceuticals, Inc.Lanthanum Carbonate
Prasco LaboratoriesLanthanum carbonate
Shire US Manufacturing Inc.Fosrenol